| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | YB2EWE6139 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Endoglin inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hemangiosarcoma | 3 | D006394 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Macular Degeneration | 2 | D008268 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Trophoblastic Tumor, Placental Site | 2 | D018245 | ClinicalTrials |
| Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
| Choriocarcinoma | 2 | D002822 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Lung Neoplasms | 1 | D008175 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Astrocytoma | 1 | D001254 | ClinicalTrials |
| Oligodendroglioma | 1 | D009837 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Gliosarcoma | 1 | D018316 | ClinicalTrials |
| Neoplasm Metastasis | 1 | D009362 | ClinicalTrials |
| Sarcoma | 1 | D012509 | ClinicalTrials |
| Glioma | 1 | D005910 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109321 |
| FDA SRS | YB2EWE6139 |
CONTENTS